Insys Therapeutics leaps following earnings beat

|About: Insys Therapeutics, Inc. (INSY)|By:, SA News Editor

Insys (INSY +21%) jumps after Q4 results beat consensus.

Insys swings to a net profit of $24.1M from a loss of $7.1M a year earlier.

Sales of Subsys +38% on quarter to $39.2M.

Shares are up a whopping eight-fold from Insys' IPO price of $8 on May 2.

The company didn't provide guidance in its PR but analysts expect EPS of $0.48 in Q1 and $2.02 in 2014.

Mutual fund ownership has skyrocketed from 1 to 143 in the past 4 quarters. (PR)